journal article·2025-02-10

Multifunctional Cu3BiS3-BP@PEI Radiosensitizer with Enhanced Reactive Oxygen Species Activity for Multimodal Synergistic Therapy

Hanping Fu, Yan Xie, Shufen Ren, Qing Zhang, Jiayun Cheng, Qingshuang Liang, Xiufeng Xiao

Publisher page

Abstract

Development of radiosensitizers with high-energy deposition efficiency, electron transfer, and oxidative stress amplification will help to improve the efficiency of radiotherapy. To overcome the drawbacks of radiotherapy alone, it is also crucial to design a multifunctional radiosensitizer that simultaneously realizes multimodal treatment and tumor microenvironment modulation. Herein, a multifunctional radiosensitizer based on the Cu 3 BiS 3 -BP@PEI nanoheterostructure (NHS) for multimodal cancer treatment is designed. Cu 3 BiS 3 -BP@PEI NHS is able to deposit a high radiation dose into cancer cells, enhancing the radiotherapy effect. Due to the heterostructure and the synergistic effect of Cu 3 BiS 3 and black phosphorus (BP), significantly boosted 1 O 2 and •OH generation is obtained under X-ray irradiation, which is promising for extremely efficient radiodynamic therapy. More importantly, the acidic tumor microenvironment (TME) can induce the cycle conversion of Cu 2+ to Cu +, oxidizing glutathione (GSH) and catalyzing intracellular overproduction of H 2 O 2 into highly toxic •OH, which thus further enhances reactive oxygen species (ROS) production and reduces GSH-associated radioresistance. Furthermore, Cu 3 BiS 3 -BP@PEI NHS has an excellent photothermal effect and can effectively transform light into heat. The outcomes of the in vitro and in vivo research confirm that the as-prepared Cu 3 BiS 3 -BP@PEI NHS has a high synergistic therapeutic efficacy at a low radiation dose. This work provides a viable approach to constructing a multifunctional radiosensitizer for deep tumor treatment with TME-triggered multiple synergistic therapies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Luminescence Properties of Advanced Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Fujian Provincial Key Laboratory of Advanced Materials Oriented Chemical Engineering, Fujian-Taiwan Science and Technology Cooperation Base of Biomedical Materials and Tissue Engineering, Engineering Research Center of Industrial Biocatalysis, College of Chemistry and Materials Science

Fujian Normal University

Funding

Natural Science Foundation of Fujian Province · Fuzhou Science and Technology Bureau · Fujian Province Guiding Projects for Social Development

References (46)

Show source-provided references
1. 10.1002/adma.20170099610.1002/adma.201700996 ↗
2. 10.1002/adma.20180224410.1002/adma.201802244 ↗
3. 10.1021/acsnano.9b0597610.1021/acsnano.9b05976 ↗
4. 10.1002/chem.20180158810.1002/chem.201801588 ↗
5. 10.1021/acsnano.0c0945410.1021/acsnano.0c09454 ↗
6. 10.1016/j.biomaterials.2019.11940510.1016/j.biomaterials.2019.119405 ↗
7. 10.1021/acsnano.8b0150810.1021/acsnano.8b01508 ↗
8. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
9. 10.1002/anie.20171202710.1002/anie.201712027 ↗
10. 10.1002/aoc.763810.1002/aoc.7638 ↗
11. 10.1002/advs.20240203910.1002/advs.202402039 ↗
12. 10.1016/j.cej.2018.09.07610.1016/j.cej.2018.09.076 ↗
13. 10.7150/thno.7303910.7150/thno.73039 ↗
14. 10.1002/smll.20190325410.1002/smll.201903254 ↗
15. 10.1021/jacs.7b0555910.1021/jacs.7b05559 ↗
16. 10.1002/adma.20200689210.1002/adma.202006892 ↗
17. 10.1016/j.biomaterials.2019.04.02310.1016/j.biomaterials.2019.04.023 ↗
18. 10.1016/j.mattod.2015.11.02510.1016/j.mattod.2015.11.025 ↗
19. 10.1002/adhm.20210201710.1002/adhm.202102017 ↗
20. 10.1002/adfm.20211335310.1002/adfm.202113353 ↗
21. 10.1002/adfm.20220079110.1002/adfm.202200791 ↗
22. 10.1002/smll.20240058710.1002/smll.202400587 ↗
23. 10.1002/ppsc.20220013810.1002/ppsc.202200138 ↗
24. 10.1021/acsami.0c0118910.1021/acsami.0c01189 ↗
25. 10.1002/adma.20200788810.1002/adma.202007888 ↗
26. 10.1002/advs.20200333810.1002/advs.202003338 ↗
27. 10.1038/s41467-020-20860-310.1038/s41467-020-20860-3 ↗
28. 10.1002/adhm.20200202410.1002/adhm.202002024 ↗
29. 10.1021/acsnano.1c0917110.1021/acsnano.1c09171 ↗
30. 10.1039/C7NR02213A10.1039/C7NR02213A ↗
31. 10.1002/EXP.2021023810.1002/EXP.20210238 ↗
32. 10.1002/anie.20180566410.1002/anie.201805664 ↗
33. 10.1016/j.nantod.2021.10116210.1016/j.nantod.2021.101162 ↗
34. 10.1002/anie.20221041510.1002/anie.202210415 ↗
35. 10.1002/adhm.20210197110.1002/adhm.202101971 ↗
36. 10.1002/adfm.20210437810.1002/adfm.202104378 ↗
37. 10.1002/adfm.20200621610.1002/adfm.202006216 ↗
38. 10.1016/j.biomaterials.2016.03.02210.1016/j.biomaterials.2016.03.022 ↗
39. 10.1002/adhm.20180060210.1002/adhm.201800602 ↗
40. 10.1038/s43018-024-00738-910.1038/s43018-024-00738-9 ↗
41. 10.1021/acs.chemrev.7b0016110.1021/acs.chemrev.7b00161 ↗
42. 10.1021/jacs.8b0071910.1021/jacs.8b00719 ↗
43. 10.1038/nature0773310.1038/nature07733 ↗
44. 10.1002/adma.20170561110.1002/adma.201705611 ↗
45. 10.1039/C9NJ01249D10.1039/C9NJ01249D ↗
46. 10.1002/ppsc.20140023810.1002/ppsc.201400238 ↗